“…There is , however , evidence from ex vivo canine studies that it is cyclo-oxygenase (COX) type 2 selective while some authors suggest that it has limited COX activity 1,31 . With a half maximal inhibitory concentration (IC50) ratio, COX-2/COX-1, of 0.04-0.4, carprofen produces preferential inhibition of COX-2 when compared with most other NSAIDs 3,22 . The products of COX-2 are thought to be responsible for the inflammatory process, while cyclo-oxygenase COX-1, which is produced continuously in small quantities is responsible for production of the homeostatic prostaglandin and thromboxane mediators 28,31 .…”